Feed Preview
Angelman Syndrome
Linyan Meng et alAngelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.
Top 20 most recent papers
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
Lancet NeurologyNovember 13, 2019
Gregory L. KraussMarc Kamin
A placebo-controlled trial of folic acid and betaine in identical twins with Angelman syndrome
Orphanet Journal of Rare DiseasesOctober 22, 2019
Julia HanVirginia E Kimonis
Modulatory effects of neuropeptides on pentylenetetrazol-induced epileptic seizures and neuroinflammation in rats
Revista da Associação Médica BrasileiraOctober 10, 2019
Erkan Kilinc, Handan Gunes
Early diagnosis improving the outcome of an infant with epileptic encephalopathy with cytoplasmic FMRP interacting protein 2 mutation: Case report and literature review
MedicineNovember 1, 2019
Min ZhongLi Jiang
1
An interaction study of Ocimum sanctum L. and levetiracetam in pentylenetetrazole kindling model of epilepsy
Journal of EthnopharmacologyNovember 15, 2019
Sudhir Chandra SarangiAmit Kumar Dinda
Imaging biomarkers of posttraumatic epileptogenesis
EpilepsiaOctober 9, 2019
Rachael GarnerDominique Duncan
10
1
Treatment of refractory and superrefractory status epilepticus with topiramate: A cohort study of 106 patients and a review of the literature
EpilepsiaNovember 11, 2019
Anne FechnerAdam Strzelczyk
24
Catalpol and Mannitol, Two Components of Rehmannia glutinosa , Exhibit Anticonvulsant Effects Probably via GABAA Receptor Regulation
Biomolecules & TherapeuticsNovember 18, 2019
Mikyung KimHee Jin Kim
Effectiveness of eslicarbazepine acetate in dependency of baseline anticonvulsant therapy: Results from a German prospective multicenter clinical practice study
Epilepsy & Behavior : E&BOctober 31, 2019
Florian WeissingerEdgar Kockelmann
Can commercially available wearable EEG devices be used for diagnostic purposes? An explorative pilot study
Epilepsy & Behavior : E&BOctober 20, 2019
Yannic TitgemeyerStephan Michael Jonas
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
EpilepsiaOctober 17, 2019
Lyndsey L AndersonJonathon C Arnold
89
1
2
Implementation of quality measures and patient-reported outcomes in an epilepsy clinic
NeurologyOctober 30, 2019
Lidia M V R MouraDaniel Brian Hoch
20
2
Connectivity measures suggest a sub-cortical generator of myoclonus in Angelman syndrome
Clinical Neurophysiology : Official Journal of the International Federation of Clinical NeurophysiologyOctober 24, 2019
Edoardo FerlazzoUmberto Aguglia
Discovery of [1,2,4]-triazolo [1,5-a]pyrimidine-7(4H)-one derivatives as positive modulators of GABAA1 receptor with potent anticonvulsant activity and low toxicity
European Journal of Medicinal ChemistryOctober 31, 2019
Long-Jiang HuangHai-bo Yu
An overview of health issues and development in a large clinical cohort of children with Angelman syndrome
American Journal of Medical Genetics. Part aNovember 15, 2019
Karen Bindels-de HeusMarie-Claire Yvette de Wit
The Potential Therapeutic Capacity of Inhibiting the Brain Renin-Angiotensin System in the Treatment of Co-Morbid Conditions in Epilepsy
CNS DrugsNovember 3, 2019
Natasha M Ivanova, Jana Dimitrova Tchekalarova
Outcome of lesional epilepsy surgery: Report of the first comprehensive epilepsy program in Iran
Neurology. Clinical PracticeAugust 1, 2019
Jafar Mehvari HabibabadiSamden D Lhatoo
Ketogenic Diet and Epilepsy
NutrientsOctober 18, 2019
Marzena Ułamek-KoziołRyszard M Pluta
28
1
Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
Journal of NeuroinflammationOctober 30, 2019
Chitra RawatRitushree Kukreti
1
Synthesis, characterization and anticonvulsant activity of new series of N-modified analogues of VV-hemorphin-5 with aminophosphonate moiety
Amino AcidsOctober 1, 2019
Petar T TodorovNadezhda Todorova